Skip to content

The Use of Barbed Sutures in Total Hip Arthroplasty

The Use of Barbed Sutures in Total Hip Arthroplasty: A Prospective, Randomized, and Controlled Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02609464
Enrollment
100
Registered
2015-11-20
Start date
2015-12-01
Completion date
2020-03-01
Last updated
2023-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Hip

Brief summary

The purpose of this study is to evaluate the role of new barbed suture for closure of wound during total hip arthroplasty in reducing the risk for wound healing problems.

Interventions

DEVICEInterrupted Knotted Sutures
DEVICESTRATAFIX Symmetric PDS PLUS Knotless Tissue Control Devices

Sponsors

Ethicon, Inc.
CollaboratorINDUSTRY
Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients receiving elective primary THA through the direct anterior approach, treated by the primary investigator (JP) at the Thomas Jefferson University Hospital or Rothman Specialty Hospital.

Exclusion criteria

* Prior surgical incision or scar in close proximity of the proposed incision (\<2 cm). * Local skin conditions such as dermatitis, eczema, or psoriasis. * Active or previous infection in the skin or the hip. * Inflammatory arthritis; connective tissue or vascular disorders or diseases that would adversely affect wound healing including the use of oral or topical cortico-steroid use

Design outcomes

Primary

MeasureTime frame
Incidence of suture abscess or other wound related compilationWithin 30 days of surgery

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026